Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repros Therapeutics Inc (NASDAQ:RPRX)

7.48
Delayed Data
As of Jul 29
 -0.03 / -0.40%
Today’s Change
5.92
Today|||52-Week Range
22.55
-24.97%
Year-to-Date
No recent news for Repros Therapeutics Inc.

Today’s Trading

Previous close7.51
Today’s open7.56
Day’s range-- - --
Volume260,300
Average volume (3 months)314,268
Market cap$182.3M
Dividend yield--
Data as of 07/29/2015

Growth & Valuation

Earnings growth (last year)-4.51%
Earnings growth (this year)+16.31%
Earnings growth (next 5 years)-21.91%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.14

Competitors

 Today’s
change
Today’s
% change
VVUSVIVUS Inc-0.08-4.42%
ACRXAcelRx Pharmaceutica...+0.01+0.25%
OCATOcata Therapeutics I...-0.19-4.30%
EPIXESSA Pharma Inc+0.58+8.02%
Data as of 07/29/2015

Financials

Next reporting dateAugust 10, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$0.00
Annual profit (last year)-$32.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Joseph S. Podolski
Secretary, Chief Financial &
Accounting Officer
Katherine A. Anderson
Corporate headquarters
Woodlands, Texas

Forecasts